lthough B-type natriuretic peptide (BNP) has emerged as an important predictor not only for heart failure but also for myocardial ischemic events, 1-4 its effect on scintigraphic parameters derived from single-photon emission computed tomography (SPECT) is unknown. We previously reported in the Quantitative gated SPECT Prognostic Value in the Elderly (Q-PROVE) study that stress myocardial SPECT successfully stratified the risk for subsequent cardiac events in 175 elderly patients with a mean age of 79 years. 5 In addition to the prognostic value of myocardial SPECT, therefore, we performed a post-hoc analysis of the Q-PROVE study to elucidate the prognostic value of BNP in elderly patients with known or suspected coronary artery disease (CAD).
Follow-up
Patient follow-up was performed by each of the 11 study centers by physician contact or mailing to patients. The follow-up period was defined as the time from the SPECT study until a significant event or the last visit to each institution until the study period endpoint in April 2006.
Significant events were considered to be death, nonfatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, malignant arrhythmias, or hospital admission because of heart failure or unstable angina, which were defined as described previously. 11, 12 All patients who were admitted to hospital because of heart failure required roentgenographic evidence of pulmonary congestion. Deaths were classified as either cardiac or noncardiac. Follow-up to event or death was ascertained in 102 of 102 patients by the endpoint of the study period.
Statistical Analysis
Results are expressed as means ± SD. Student's t-test was used to compare the means of the continuous variables, and categorical variables were analyzed using the chi-square test. To determine a cutoff value of BNP and summed scores for subsequent prognosis, receiver-operating characteristic (ROC) curve analysis was performed. For survival analysis, Kaplan-Meier estimation using a log-rank test was performed. Multivariate analysis of outcome was assessed using the Cox proportional hazard model. A value of P< 0.05 was considered as statistically significant. Statistical analyses were performed using the SPSS-PC+ computation program (version 11.0, SPSS Inc, Chicago, IL, USA).
Results

Overall Results
The mean age of the 102 patients who completed follow-up was 79±3 years; there were 59 men and 43 women. For stress SPECT, 35 patients (34%) underwent exercise stress and the remaining 67 (66%) had vasodilator pharmacologic loading. The left ventricular volumetric and functional measurements were successful in 100 patients (98%), but could not be performed in the remaining 2 patients because of frequent extrasystoles.
A mean level of BNP was 73.5±137.7 pg/ml (3.4-1,310 pg/ml). Weak but significant correlations were observed between BNP and SSS (r=0.32; P=0.001), SRS (r=0.25; P=0.001) and SDS (r=0.22; P=0.03). The ROC curve analysis revealed a BNP level of 130 pg/ml as the cutoff point for the prognosis of elderly patients in this cohort. Accordingly, using 130 pg/ml as the cutoff, the clinical characteristics of patients who had a high BNP level (>130 pg/ml) and those who had a low BNP level (≤130 pg/ml) are shown in Table 1 . Age, gender, and the prevalence of classical coronary risk factors were similar in the 2 groups ( Table 1) . Although 40 patients (39%) had had a previous myocardial infarction, coronary revascularization or both, the frequency of revascularization history was more common in patients with a high BNP level than in those with a low level ( Table 1) . ECG-gated SPECT showed that the SSS was greater in patients with a high BNP level than in those with a low BNP level. Although the ejection fraction was lower in patients with a high BNP level than in those with a low BNP level, end-diastolic volume, end-systolic volume, SRS, and SDS were similar in the 2 groups ( Table 2) .
During a mean follow-up of 3.4±0.6 years (median, 3.8 years), 17 patients had significant events, of whom 3 patients died from noncardiac causes, and the remaining 14 patients had cardiac events: cardiac death in 2, heart failure that needed hospital admission in 4, percutaneous coronary intervention in 6, coronary artery bypass grafting in 1, unstable angina in 1. The clinical characteristics of patients who subsequently had cardiac events and those who were free of cardiac events are shown in Table 3 . Age, gender, the prevalence of classical coronary risk factors and medications were similar in patients with and without cardiac events, although patients with a high BNP level were more frequently observed among those with cardiac events than among those without ( Table 3) . ECG-gated SPECT showed that end-diastolic volume, SSS and SDS were greater in patients with cardiac events than in those without, whereas end-systolic volume, ejection fraction and SRS were similar in the 2 groups (Table 4) .
BNP, Gated SPECT and Prognosis
Kaplan-Meier survival estimation was performed based on a BNP with a cutoff of 130 pg/ml. The cardiac event-free survival rate in patients with a low BNP level was 99% at 1 year and 98% at 3 years, which was higher than the 100% at 1 year and 83% at 3 years in patients with a high BNP level (P=0.006, log-rank =7.7) (Figure 2A) .
To analyze the SPECT data, the cutoff values were set according to ROC curve analysis as follows: 7 for the SSS, 3 for the SRS and 2 for the SDS. In addition, gender-spe- cific normalcy for the volumetric analysis derived from the J-ACCESS database was applied. 10 Kaplan-Meier survival curves, which showed statistical significance by the univariate analyses, are shown in Figures 2 and 3 . The cardiac event-free survival rate in patients with a SSS <7 was 98% at 1 year and 98% at 3 years, which was higher than the 85% at 1 year and 78% at 3 years in those with a SSS ≥7 (P=0.005, log-rank =8.1) (Figure 2B ). The cardiac eventfree survival rate in patients with a SDS <2 was 100% at 1 year and 100% at 3 years, which was also significantly higher than the 97% at 1 year and 88% at 3 years in those with a SDS ≥2 (P=0.0008, log-rank =11.3) (Figure 3A) . Kaplan-Meier survival estimates revealed that the cardiac event-free survival rate in patients with normal end-diastolic volume was 94% at 1 year and 94% at 3 years, which was higher than the 87% at 1 year and 80% at 3 years in those with dilated end-diastolic volume (P=0.01, log-rank =6.2) ( Figure 3B ).
Predictors of Cardiac Events
Thirteen variables related to clinical and scintigraphic findings ( Tables 3,4) were considered potential predictors for the occurrence of subsequent cardiac events during followup, and were included in the multivariate analysis using the Cox proportional hazard model. The analysis revealed that only SDS ≥2 was an independent predictor of cardiac events (hazard ratio (HR) =4.0, P=0.04) ( Table 5 ). The analysis was repeated without setting a cutoff point in order to exclude a potential confounding effect in the process of selecting the cutoff points. The BNP and SPECT data were included in the Cox proportional hazard model as numerical variables and the analysis again showed that the SDS was the only independent predictor for subsequent cardiac events (HR =1.1, P=0.04).
Discussion
Since the discovery of BNP, the measurements of this left ventricular-derived peptide for the management of patients with heart failure has become routine clinical practice. [14] [15] [16] [17] [18] Furthermore, recent studies showed that the BNP level predicted subsequent prognosis not only in patients with heart failure but also in those with CAD. 1, 3, 4 In the present posthoc analysis of the Q-PROVE study, a high BNP level >130 pg/ml was significantly associated with subsequent cardiac events in 102 elderly patients with known or suspected CAD. The cardiac event-free survival rate in patients with a high BNP level was 83% at 3 years, which was lower than the 98% at 3 years in patients with a low BNP level (Figure 2A) . When the patient population of the current study consisting of 102 elderly patients with a mean age of 79 years is taken into consideration, BNP may have a clinical role in risk stratification even in elderly patients aged 75 years or more who are suspected of having CAD.
In the prognostication and risk stratification of patients with known or suspected CAD, nuclear cardiology is providing accumulating evidence applicable to daily practice. [19] [20] [21] In the present study, gated SPECT also showed event-free survival rates at 3 years of 78%, 88%, and 80%, respectively, in patients with a SSS ≥7, SDS ≥2, and dilated end-diastolic volume, but 98%, 100%, and 94%, respectively in those with a SSS <7, SDS <2 and normal enddiastolic volume (Tables 3-5) . Thus, elderly patients with normal or mildly abnormal myocardial perfusion and normal left ventricular volume have a good prognosis. These observations are consistent with previous reports. [22] [23] [24] [25] To compare the prognostic impact of BNP with scintigraphic parameters, both BNP and scintigraphic parameters were evaluated by multivariate analysis. The Cox proportional hazard model revealed that the SDS was the only independent predictor of outcomes (Table 5) . Thus, although BNP may have a similar prognostic value to scintigraphic parameters in elderly patients with known or suspected CAD, myocardial ischemia as documented by SPECT is still indispensable for better detection of high-risk patients.
Normalcy for the BNP level differs according to age, gender and other factors. 26 In this study based on elderly patients aged 75 years or more, a cutoff point of 130 pg/ml was determined by ROC curve analysis and was higher than the BNP level for heart failure in middle-aged patients. 15 The left ventricular volumetric analysis as assessed by gated SPECT showed larger end-diastolic and end-systolic volumes in patients with a high BNP level than in those with a low BNP level, though this did not reach statistical significance because of the wide variation of these measurements. In contrast, the left ventricular ejection fraction was reduced significantly in patients with a high BNP level. These observations are consistent with previous studies in which the BNP level was increased in elderly subjects and/or those with impaired left ventricular systolic function. 1,27,28 In addition, BNP showed weak but significant correlations with scintigraphic summed scores. However, the best correlation was observed between BNP and the SSS, which represents the combination of myocardial scar and stressinduced ischemia. Previous studies reported significant increase in the BNP level after stress myocardial SPECT, particularly in those in whom myocardial ischemia was documented. 29, 30 Therefore, it is reasonable that the 2 markers, which are influenced not only by cardiac function but also by myocardial ischemia, showed a good relationship. Although our results indicate the superiority in prognostic value of stress myocardial SPECT to BNP in elderly patients with suspected CAD, the current study was a posthoc analysis of the Q-PROVE study. Thus, these preliminary results need confirmation through a series of largescale, prospective clinical trials.
Conclusion
Although BNP may have a similar prognostic value to gated SPECT volumetric measurements in elderly patients with known or suspected CAD, myocardial ischemia as documented by SPECT is still indispensable for better detection of high-risk patients compared with BNP alone.
